Clinical characteristics and outcomes of previously untreated patients with adult onset T-acute lymphoblastic leukemia and T-lymphoblastic lymphoma with hyper-CVAD based regimens

被引：10
|
作者：
Jain, Preetesh [1 ]
Kantarjian, Hagop [1 ]
Jain, Nitin [1 ]
Short, Nicholas J. [1 ]
Yin, Cameron C. [2 ]
Kanagal-Shamanna, Rashmi [2 ]
Khoury, Joseph [2 ]
Konopleva, Marina [1 ]
Sasaki, Koji [1 ]
Kadia, Tapan M. [1 ]
Garris, Rebecca [1 ]
Pierce, Sherry [1 ]
Estrov, Zeev [1 ]
Wierda, William [1 ]
Cortes, Jorge [1 ]
O'Brien, Susan [3 ]
Ravandi, Farhad [1 ]
Jabbour, Elias [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA
[3] Univ Calif Irvine, Chao Family Comprehens Canc Ctr, Orange, CA 92668 USA
来源：
AMERICAN JOURNAL OF HEMATOLOGY | 2017年 / 92卷 / 10期
关键词：
THERAPY;
D O I：
10.1002/ajh.24833
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E595 / E597
页数：4
相关论文
共 50 条
  • [31] Hyper-CVAD and Modified CALGB-10403 Regimens in Adult Patients With Philadelphia-Negative Acute Lymphoblastic Leukemia: A Comparative Study
    Zalapa-Soto, Jessica
    Rios-Olais, Fausto Alfredo
    Chacon-Rangel, Lyam Carlo
    Mora-Canas, Analy
    Meza-Meza, Mario
    Rangel-Patino, Juan
    Demichelis-Gomez, Roberta
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2025,
  • [32] Hyper-CVAD Regimen in Routine Management of Adult Acute Lymphoblastic Leukemia: A Retrospective Multicenter Study
    Buyukasik, Yahya
    Acar, Kadir
    Kelkitli, Engin
    Uz, Burak
    Serefhanoglu, Songul
    Ozdemir, Evren
    Pamukcuoglu, Merve
    Atay, Hilmi
    Bektas, Ozlen
    Sucak, Gulsan Turkoz
    Turgut, Mehmet
    Aksu, Salih
    Yagci, Munci
    Saymalp, Nilgun
    Ozcebe, Osman I.
    Goker, Hakan
    Haznedaroglu, Ibrahim C.
    ACTA HAEMATOLOGICA, 2013, 130 (03) : 199 - 205
  • [33] Chemoimmunotherapy with hyper-CVAD plus rituximab for the treatment of adult Burkitt and Burkitt-type lymphoma or acute lymphoblastic leukemia
    Thomas, DA
    Faderl, S
    O'Brien, S
    Bueso-Ramos, C
    Cortes, J
    Garcia-Manero, G
    Giles, FJ
    Verstovsek, S
    Wierda, WG
    Pierce, SA
    Shan, JQ
    Brandt, M
    Hagemeister, FB
    Keating, MJ
    Cabanillas, F
    Kantarjian, H
    CANCER, 2006, 106 (07) : 1569 - 1580
  • [34] High relapse rate of T cell acute lymphoblastic leukemia in adults treated with Hyper-CVAD chemotherapy in Sweden
    Kozlowski, Piotr
    Astrom, Maria
    Ahlberg, Lucia
    Bernell, Per
    Hulegardh, Erik
    Hagglund, Hans
    Karlsson, Karin
    Markuszewska-Kuczymska, Alicja
    Tomaszewska-Toporska, Beata
    Smedmyr, Bengt
    Amini, Rose-Marie
    Hallbook, Helene
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2014, 92 (05) : 377 - 381
  • [35] Retinal and Preretinal Hemorrhages in a Patient Receiving Hyper-CVAD Chemotherapy for T-Cell Acute Lymphoblastic Leukemia
    Peddada, Krishi
    Weiss, Stephanie J.
    Kumar, Shaina
    Malik, Deepika
    CASE REPORTS IN OPHTHALMOLOGICAL MEDICINE, 2018, 2018
  • [36] Complete remission with romidepsin in a patient with T-cell acute lymphoblastic leukemia refractory to induction hyper-CVAD
    Brunvand, Mark W.
    Carson, John
    HEMATOLOGICAL ONCOLOGY, 2018, 36 (01) : 340 - 343
  • [37] T-Lymphoblastic Leukemia With t(9;22): Blast Phase of Chronic Myelogenous Leukemia or BCR-ABL-Positive T-Acute Lymphoblastic Leukemia?
    Xu, Jie
    Li, Shaoying
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2012, 138 : A346 - A346
  • [38] Intensification of hyper-CVAD with L-asparaginase, vincristine, and dexamethasone ("Augmented Hyper-CVAD") has activity in adult patients with relapsed/refractory acute lymphoblastic leukemia (ALL).
    Fader, Stefan
    Thomas, Deborah A.
    Ravandi, Farhad
    Garcia-Manero, Guillermo
    Beran, Miloslav
    Rytting, Michael
    Koller, Charles A.
    Verstovsek, Srdan
    Borthakur, Gautam
    Andreeff, Michael
    Kornblau, Steve
    O'Brien, Susan
    Vu, Khanh
    Kwari, Monica
    Bretz, Jennie
    Kantarjian, Hagop M.
    BLOOD, 2007, 110 (11) : 149B - 149B
  • [39] Phase I Study of Escalating Doses of Carfilzomib with Hyper-CVAD in Patients with Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma
    Fisch, Samantha C.
    Jonas, Brian A.
    Tuscano, Joseph
    Rosenberg, Aaron Seth
    Hoeg, Rasmus T.
    Abedi, Mehrdad
    BLOOD, 2019, 134
  • [40] Effectiveness of modified hyper-CVAD chemotherapy regimen in the treatment of adult acute lymphoblastic leukemia: a retrospective experience
    Jalaeikhoo, Hasan
    Rajaeinejad, Mohsen
    Keyhani, Manoutchehr
    Zokaasadi, Mohammad
    Firoozabadi, Mohammad Mehdi Dehghani
    CANCER MEDICINE, 2018, 7 (03): : 594 - 599
12345